Novartis Pharmaceuticals Corporation
Registered Principal Details
Cessation Date
6/2/2014 3:16:00 PM
Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Andre Wyss
Executive Director
6/2/2014 3:16:00 PM
Business Or Interest:
All matters affecting pharmaceutical manufacturing and health care.
Lobbying Interests:
Mental health issues; drug pricing issues; health care reform; access; coverage; budgets.
CEO Name:
Andre Wyss
Executive Director
Contact
GS
Gregory Slyfield
One Health Plaza, Building 701/433
East Hanover, NJ 07936
(862) 778-6664
(973) 781-6671
gregory.slyfield@novartis.com
http://www.novartis.com
One Health Plaza, Building 701/433
East Hanover, NJ 07936
(862) 778-6664
(973) 781-6671
gregory.slyfield@novartis.com
http://www.novartis.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|---|---|---|
| Lisa Steelman | Exclusive Duties N/A | Authorized On 12/5/2012 | Withdrawn On 6/2/2014 |
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 392
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
Other
Notification Date2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 445
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
Bill Text and History
2013 Wisconsin Act 199
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
Bill Text and History
2013 Wisconsin Act 199
Other
Notification Date2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 448
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)
Bill Text and History
2013 Wisconsin Act 198
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)
Bill Text and History
2013 Wisconsin Act 198
Other
Notification Date2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 300
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
2013 Wisconsin Act 186
10/16/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
Bill Text and History
2013 Wisconsin Act 186
For
Notification Date10/16/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 351
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)
Bill Text and History
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)
Bill Text and History
Other
Notification Date2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 353
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
Bill Text and History
2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
Bill Text and History
Other
Notification Date2/3/2014
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
LRB−1961/1: Health Benefit Exchange (Craig) Requiring legislation for agencies to take an action to, request federal moneys to, and use state moneys to assist the federal government to create or implement a health benefits exchange
Development, drafting or introduction of a proposal relating to
LRB−1961/1: Health Benefit Exchange (Craig) Requiring legislation for agencies to take an action to, request federal moneys to, and use state moneys to assist the federal government to create or implement a health benefits exchange
LRB−1961/1: Health Benefit Exchange (Craig) Requiring legislation for agencies to take an action to, request federal moneys to, and use state moneys to assist the federal government to create or implement a health benefits exchange
Action Intended To Affect
Legislative matter
Notification Date
10/25/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
10/25/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
LRB-3279/1. Medical Assistance (Sanfelippo) Mental health benefits and reimbursement for mental health services under the Medical Assistance program
Position: Monitoring
Development, drafting or introduction of a proposal relating to
LRB-3279/1. Medical Assistance (Sanfelippo) Mental health benefits and reimbursement for mental health services under the Medical Assistance program Position: Monitoring
LRB-3279/1. Medical Assistance (Sanfelippo) Mental health benefits and reimbursement for mental health services under the Medical Assistance program Position: Monitoring
Action Intended To Affect
Legislative matter
Notification Date
10/16/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
10/16/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2013 January - June |
2013 July - December |
2014 January - June |
Total | |
|---|---|---|---|---|
| Total Lobbying Expenditures | 2013 January - June $2,771.52 |
2013 July - December $5,797.33 |
2014 January - June $4,082.62 |
Total $12,651.46 |
| Total Hours Communicating | 2013 January - June 0.00 |
2013 July - December 0.00 |
2014 January - June 0.00 |
Total 0.00 |
| Total Hours Other | 2013 January - June 19.50 |
2013 July - December 35.50 |
2014 January - June 25.00 |
Total 80.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December |
2014 January - June 5% |
2014 July - December |
Total 1% |
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December |
2014 January - June 5% |
2014 July - December |
Total 1% |
Relating to: programs for the disposal of drugs, including controlled substances, and certain medical or drug-related items, and the regulation of prescription drugs. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December |
2014 January - June 5% |
2014 July - December |
Total 1% |
Relating to: identification presentation and monitoring for certain prescription drugs. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December |
2014 January - June 5% |
2014 July - December |
Total 1% |
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December |
2014 January - June 15% |
2014 July - December |
Total 5% |
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
| 2013 January - June |
2013 July - December |
2014 January - June |
2014 July - December |
Total |
|---|---|---|---|---|
| 2013 January - June |
2013 July - December |
2014 January - June 15% |
2014 July - December |
Total 5% |
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
No topics found.
Minor Efforts
No minor efforts found.
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication